Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.796
-0.040 (-4.74%)
At close: Oct 29, 2024, 4:00 PM
0.791
-0.004 (-0.53%)
After-hours: Oct 29, 2024, 7:05 PM EDT
Vaxart Market Cap
Vaxart has a market cap or net worth of $180.93 million as of October 29, 2024. Its market cap has increased by 78.96% in one year.
Market Cap
180.93M
Enterprise Value
141.47M
1-Year Change
78.96%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since December 1, 1998, Vaxart's market cap has increased from $89.40M to $180.93M, an increase of 102.38%. That is a compound annual growth rate of 2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 189.90M | 118.03% |
| Dec 29, 2023 | 87.10M | -30.93% |
| Dec 30, 2022 | 126.10M | -83.98% |
| Dec 31, 2021 | 786.90M | 25.88% |
| Dec 31, 2020 | 625.10M | 3,643.11% |
| Dec 31, 2019 | 16.70M | 24.63% |
| Dec 31, 2018 | 13.40M | -38.81% |
| Dec 29, 2017 | 21.90M | -53.89% |
| Dec 30, 2016 | 47.50M | -36.67% |
| Dec 31, 2015 | 75.00M | -4.58% |
| Dec 31, 2014 | 78.60M | -33.84% |
| Dec 31, 2013 | 118.80M | 531.91% |
| Dec 31, 2012 | 18.80M | -76.67% |
| Dec 30, 2011 | 80.60M | -67.21% |
| Dec 31, 2010 | 245.80M | -1.17% |
| Dec 31, 2009 | 248.70M | 42.93% |
| Dec 31, 2008 | 174.00M | -21.20% |
| Dec 31, 2007 | 220.80M | -46.13% |
| Dec 29, 2006 | 409.90M | 104.24% |
| Dec 30, 2005 | 200.70M | -76.55% |
| Dec 31, 2004 | 855.90M | 44.31% |
| Dec 31, 2003 | 593.10M | 147.13% |
| Dec 31, 2002 | 240.00M | -38.92% |
| Dec 31, 2001 | 392.90M | 125.03% |
| Dec 29, 2000 | 174.60M | 7.98% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 201.24M |
| Cabaletta Bio | 200.28M |
| Corbus Pharmaceuticals Holdings | 196.80M |
| Kodiak Sciences | 195.78M |
| Sagimet Biosciences | 191.16M |
| MediWound | 189.52M |
| LifeMD | 189.29M |
| TruBridge | 189.13M |